Carvedilol to Improve Cardiac Remodeling in Anthracycline-Exposed Childhood Cancer Survivors: Subgroup Analysis of COG ALTE1621
JACC CardioOncol
.
2024 Sep 17;6(5):791-793.
doi: 10.1016/j.jaccao.2024.07.015.
eCollection 2024 Oct.
Authors
Saro H Armenian
1
2
,
Melissa M Hudson
3
4
,
Lanie Lindenfeld
1
2
,
Sitong Chen
1
,
Eric J Chow
5
,
Steven Colan
6
,
Meagan Echevarria
1
,
F Lennie Wong
1
,
Ming Hui Chen
6
,
Smita Bhatia
7
Affiliations
1
Division of Outcomes Research, City of Hope, Duarte, California, USA.
2
Department of Pediatrics, City of Hope, Duarte, California, USA.
3
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
4
Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
5
Clinical Research and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
6
Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts, USA.
7
Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, Alabama, USA.
PMID:
39479331
PMCID:
PMC11522501
DOI:
10.1016/j.jaccao.2024.07.015
No abstract available
Keywords:
biomarkers; cancer survivorship; cardiomyopathy; echocardiography; prevention.